SCHEMBL2704089

SCHEMBL2704089

COc1cc(OC)nc(N=C=O)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
CYP1A2 P05177 1/20 0.41
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PDE2A O00408 1/20 0.37
RECQL P46063 1/20 0.35
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
PAX8 Q06710 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8446835 0.85 GAA (0.43) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL9877006 0.81 L3MBTL1 (0.47) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL1577289 0.74 TDP1 (0.38) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL3062992 0.73 POLB (0.37) LMNAALDH1A1CYP3A4KDM4EGAA
SCHEMBL28377189 0.73 L3MBTL1 (0.52) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL10647845 0.71 L3MBTL1 (0.50) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL15674890 0.71
SCHEMBL10394269 0.71 L3MBTL1 (0.39) L3MBTL1SMN1; SMN2CYP1A2ALDH1A1CYP3A4
SCHEMBL2393278 0.70 L3MBTL1 (0.37) L3MBTL1LMNASMN1; SMN2CYP1A2ALDH1A1
SCHEMBL13026224 0.69 GAA (0.34) ALDH1A1TDP1CYP3A4HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0916660-B1 Process for the production of sulphonylurea salts SYNGENTA PARTICIPATIONS AG (CH) 2005-11-16 EP claimed
US-6410730-B2 PREPARING N-PYRIDYLSULFONYL-N'-PYRIMIDINYLUREA SODIUM AND POTASSIUM SALTS BY REACTING A PYRIDYLSULFONAMIDE SALT WITH A PYRIMIDINYL ISOCYANATE, OR A PYRIDYLSULFOCHLORIDE WITH A PYRIMIDINYLUREA SALT SYNGENTA CROP PROTECTION, INC. 2002-06-25 US claimed
US-20010008938-A1 Process for preparation of sulfonylurea salts JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP 2001-07-19 US claimed
US-6222037-B1 REACTING 4,6-DIMETHOXYPYRIMIDIN-2-ISOCYANTE WITH 2-SULFONAMIDO-PYRIDINE COMPOUND IN APROTIC SOLVENT TO FORM POTASSIUM OR SODIUM N-PYRIDYLSULFONYL-N'-PYRIMIDINYLUREA COMPOUND SYNGENTA CROP PROTECTION, INC. 2001-04-24 US claimed
WO-2000052006-A1 SULFONYLUREA SALTS AS HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2000-09-08 WO claimed
EP-0916660-A2 Process for the production of sulphonylurea salts Novartis AG (CH) 1999-05-19 EP claimed
EP-0184385-B1 N-[(4,6-Dimethoxypyrimidin-2-YL)Aminocarbonyl]-3-trifluoromethylpyridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and processs for the production of the compound ISHIHARA SANGYO KAISHA LTD. (JP) 1990-09-26 EP claimed
EP-0184385-A2 N-[(4,6-Dimethoxypyrimidin-2-YL)Aminocarbonyl]-3-trifluoromethylpyridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and processs for the production of the compound ISHIHARA SANGYO KAISHA LTD. (JP) 1986-06-11 EP claimed
JP-11140081-A None JP disclosed
CN-114933587-A Preparation method of trifloxysulfuron sodium salt 江苏省农用激素工程技术研究中心有限公司 2022-08-23 CN disclosed
CN-110878084-A Preparation method of nicosulfuron original drug 郑州手性药物研究院有限公司 2020-03-13 CN disclosed
CN-108558830-B A kind of synthetic method of nicosulfuron raw medicine 河南恒诚药业有限公司 2019-09-20 CN disclosed
CN-108558830-A A kind of synthetic method of nicosulfuron active compound 河南恒诚药业有限公司 2018-09-21 CN disclosed
CN-106349168-A Preparation method of foramsulfuron intermediate of sulfonylurea herbicide 淮安国瑞化工有限公司 2017-01-25 CN disclosed
US-4935528-A HERBICIDES ISHIHARA SANGYO KAISHA LTD. (JP) 1990-06-19 US disclosed
US-4835282-A Isothiazoles as intermediates for herbicidal sulfonamides ISHIHARA SANGYO KAISHA LTD. (JP) 1989-05-30 US disclosed
US-4822402-A NONPHYTOTOXIC POSTEMERGENCE WEED CONTROL IN PADDY RICE FIELDS ISHIHARA SANGYO KAISHA LTD. (JP) 1989-04-18 US disclosed
EP-0298752-A2 Mercapto-substituted pyridine compounds and process for preparing the same ISHIHARA SANGYO KAISHA, LTD. (JP) 1989-01-11 EP disclosed
US-4790869-A Sulfonamide compounds and salts thereof, herbicidal compositions containing them ISHIHARA SANGYO KAISHA LTD. (JP) 1988-12-13 US disclosed
EP-0234352-A1 Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them ISHIHARA SANGYO KAISHA, LTD. (JP) 1987-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008938-A1 Process for preparation of sulfonylurea salts KCNH1, CLIC1, KCNH3 L3MBTL1 4362/4885LMNA 1931/4885SMN1; SMN2 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.